Biologics Consortium Plans Collaborative Approach To Rapid Methods Validation
Executive Summary
A plan to develop a “best practices” guide on validating rapid analytical methods for biopharmaceuticals is in the works.
You may also be interested in...
USP Sparks Debate Over Rapid Sterility Testing For Cell And Gene Therapies
For short-lived cell and gene therapies that must be given to patients before traditional sterility testing results can be obtained, the question is whether less sensitive rapid tests that can be completed in advance might be a better choice. Should manufacturers demonstrate a lack of viable microorganisms, or is it OK merely to show there aren’t enough of them to produce an “infectious dose”?
Industry Roadmap Offers Route To Flexible, Low-Cost Biopharmaceutical Manufacturing
A biopharmaceutical industry consortium has released a roadmap to help the industry achieve the flexibility and cost reductions needed to deal with a changing business and manufacturing environment. The group is promoting the use of six enabling technologies.
Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”